Evaluating psychotherapy
Abstract
The authors analyze the possible need for a standing national group to evaluate the efficacy and safety of the psychotherapies. The current need is for a body whose function is more scientifically evaluative and less regulatory than the Food and Drug Administration because available psychotherapies are less specific in their beneficial effects and less dangerous than are drugs and because the practice of psychotherapy cannot be restricted entirely to the health professions. Even so, the authors believe the main criteria for discerning the boundaries between research and established practice are in principle at least as clear for psychotherapy as for other health interventions.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
